Image Source: UnsplashMedipal Holdings Corp. (MAHLY) distributes pharmaceuticals and health and beauty products to medical institutions and retailers.The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale.The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives.Medipal Holdings generates the vast majority of its revenue in Japan.The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009.The company was founded in 1898 and is headquartered in Tokyo, Japan.Three key data points gaugeMedipal Holdings Corp or any dividend-paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three basic keys best tell whether any company has made, is making, and will make money.MAHLY PriceOver the past year, Medipal share price rose 18.6% from $13.10 to $15.54 as of Thursday’s market close.If Medipal Holdings Corp shares trade in the range of $13.00 to $20.00 this next year, its recent $15.54 share price might rise to $16.20 by next year. Of course, Medipal’s price could drop about the same $0.66 estimated amount or more.My annual upside estimate of $0.66 however, is calculated at a midpoint between the company’s average annual price gain over the past nine years and the same average over the past two years.MAHLY DividendMedipal Holdings Corp has paid variable semi-annual dividends since June 2014. Medipal’s recent SA dividend of $0.20 was declared on September 21, 2023, to shareholders of record on September 28th. The payout was made on December 18th.The forward-looking $0.40 annual dividend yields 2.57% at Thursday’s $15.54 share price.MAHLY ReturnsTo put it all together, add Medipal’s stated annual dividend of $0.40 to the estimated price upside of $0.66 to find a $1.06 gross gain.At Thursday’s $15.54 share price, a little under $1000 would buy 64 shares.A $10 broker fee (if charged), paid half at purchase and half at sale, would cost us  $0.155 per share.Subtracting that likely $0.155 brokerage cost from the $1.06 gross gain produces a net gain of $0.905 X 64 shares = $57.92 for a 5.8% estimated net gain on the year.You might choose to pounce on Medipal Holdings Corp It is a 126-year-old dividend-paying Japanese medical distribution company.  Furthermore, the estimated $25.70 annual dividend income from $1k invested is over 1.65 times greater than Medipal’s recent $15.54 single share price.The exact track of Medipal’s ongoing future price and dividend will be determined by market action.Remember the true value of any stock is best realized through personal ownership of shares.More By This Author:Current Analysis: Haleon
Current Analysis: Getinge AB
Current Analysis: Elekta AB (EKTAF)